Expression of miR-106b in clear cell renal cell carcinoma is a potential marker for prediction of early metastasis after nephrectomy.

SLABÝ, Ondřej, Radek LAKOMÝ, Marek SVOBODA, Jana JANČOVIČOVA, Alexandr POPRACH, Renata HÉŽOVÁ, Petra FALTEJSKOVÁ, Pavel FABIAN, Jan HODEK, Jaroslava OVESNÁ, Sabina ŠEVČÍKOVÁ, Jaroslav MICHÁLEK and Rostislav VYZULA. Expression of miR-106b in clear cell renal cell carcinoma is a potential marker for prediction of early metastasis after nephrectomy. In RNAi & miRNA Europe, qPCR Europe, Epigenetics Europe, Genomics Automation Europe. 2010.

Basic information

Original name

Expression of miR-106b in clear cell renal cell carcinoma is a potential marker for prediction of early metastasis after nephrectomy.

Authors

SLABÝ, Ondřej, Radek LAKOMÝ, Marek SVOBODA, Jana JANČOVIČOVA, Alexandr POPRACH, Renata HÉŽOVÁ, Petra FALTEJSKOVÁ, Pavel FABIAN, Jan HODEK, Jaroslava OVESNÁ, Sabina ŠEVČÍKOVÁ, Jaroslav MICHÁLEK and Rostislav VYZULA

Edition

RNAi & miRNA Europe, qPCR Europe, Epigenetics Europe, Genomics Automation Europe, 2010

---

Other information

Language

English

Type of outcome

Konferenční abstrakt

Field of Study

30200 3.2 Clinical medicine

Country of publisher

Ireland

Confidentiality degree

není předmětem státního či obchodního tajemství

Organization unit

Masaryk Memorial Cancer Institute

Keywords in English

microRNA; renal cell carcinoma; metastasis; nephrectomy

Tags

International impact